Evolving role of Sorafenib in the management of hepatocellular carcinoma

DOI: 10.5306/wjco.v8.i3.203

Keywords: Sorafenib, Hepatocellular carcinoma, Liver neoplasm, Multikinase inhibitor, Targeted therapy, Tumor angiogenesis, Signaling pathways, Adjuvant therapy, Liver cancer, Liver transplantation, Liver resection

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text